An inferior vena cava filter is a cardiovascular intravascular filter placed in the vena cava to help prevent a blood clot from reaching the lungs in selected circumstances. A product-liability review should begin with the exact device and record, not with national litigation figures or assumptions about every filter.

The medical decision to use or remove a filter and the product-liability evaluation of the device are related but separate inquiries.

Identify the actual filter before evaluating a product theory

The FDA product-classification database lists the intravascular vena cava filter as a Class II cardiovascular device under product code DTK. A patient record may use a trade name, manufacturer, model, catalog number, lot or serial information, or a unique device identifier. The available fields differ by device and facility.

  • Implant date, facility, clinician, operative or procedure note, consent record, order, indication as documented, and imaging
  • Manufacturer, trade name, model, catalog number, lot or serial information, unique device identifier, label, packaging, and implant card when available
  • Device location and condition described in later imaging or procedure records, symptoms and diagnoses attributed to their sources, and other possible causes
  • Retrieval consultation, attempted or completed procedure, reason documented, device returned or retained, pathology or engineering examination, and chain of custody
  • Recall, correction, safety communication, complaint, adverse-event report, instructions for use, and labeling matched to the exact device and date

Do not convert an FDA communication into individual medical direction

A 2021 FDA announcement concerning an IVC-filter removal device describes the role of IVC filters and refers to the agency's 2014 safety communication recommending that clinicians consider removal of an IVC filter when protection from pulmonary embolism is no longer needed. That history is not a treatment recommendation for a particular person.

Questions about a filter's present condition, anticoagulation, imaging, retrieval, or other care belong with an appropriate treating professional. A legal review should record what was recommended, when, by whom, on what information, and what happened rather than direct a medical course.

A warning theory has specific North Carolina elements

G.S. 99B-5 addresses product-liability claims based on inadequate warning or instruction. Among other requirements, the statute addresses whether the manufacturer or seller acted unreasonably in failing to provide an adequate warning or instruction and whether that failure was a proximate cause of harm. It also addresses warning a prescribing or other legally authorized health care provider for prescription drugs and medical devices.

The analysis therefore needs the label and instructions that accompanied the device at the relevant time, the information available to the manufacturer or seller, communications to the health care provider, what the provider knew, what was conveyed to the patient, and how a different warning allegedly would have changed the causal sequence.

A design theory asks a different question

G.S. 99B-6 addresses claims that a product was designed in a way that made it unreasonably dangerous. The statute includes a reasonable-alternative-design path and a separate path involving a design so unreasonable that a reasonable person, aware of the relevant facts, would not use or consume the product.

Device identification, condition, engineering evidence, intended and foreseeable uses, risk-utility evidence, regulatory history, alternative design, feasibility, and causation should be developed for the exact product. A complication or later removal difficulty does not by itself establish a statutory design claim.

Keep product and medical-care records connected but distinct

  • Product claim: manufacturer or seller, exact device, warning, design, condition, distribution history, alteration, use, and statutory causation
  • Medical-care question: provider role, indication, procedure, follow-up, communication, standard alleged, professional evidence, and medical causation
  • Damages record: condition before implantation, alleged event, treatment, work and daily-life effects, expenses, and source for each claimed connection
  • Evidence controls: original records and images, native electronic files, physical device, chain of custody, notices, preservation requests, and later changes

The related guide to North Carolina product-liability claims under Chapter 99B explains why the required theory must be identified instead of relying on a general “strict liability” label. This page applies that distinction to IVC-filter evidence.

Rosensteel Fleishman Car Accident & Injury Lawyers provides information about consulting a Charlotte personal injury lawyer about an IVC-filter product claim. Device identity, product history, medical records, legal theory, causation, defendants, defenses, and deadlines require individual review.

Sources